incretin mimetics glp 1 agonists A Brief Review of Intended for the Management of Diabetes and Associated Comorbidities[v1] The Influence of Glucagon-like Peptide-1

Moreover, the low or middle-income countries are unable to afford them

Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis was published in The BMJ in January 2024

It enrolled 17,604 adults aged 45 or older with a body mass index (BMI) of 27 kg/m2 or greater and preexisting CVD (prior MI, prior stroke or peripheral artery disease) without diabetes

It mimics a natural hormone our bodies make (GLP-1 analogs), to help regulate blood sugar, curb appetite, and support sustainable weight loss

if blood sugar drops too low, it can lead to blurred vision

We discuss subpopulations who may benefit from their BP-lowering effects, identify limitations in the existing evidence, and explore future directions for research